Related Experiment Videos
Covalently conjugated VEGF--fibrin matrices for endothelialization
A H Zisch1, U Schenk, J C Schense
1Department of Materials and Institute for Biomedical Engineering, ETH and University of Zurich, Moussonstrasse 18, 8044 Zurich, Switzerland. zisch@biomed.mat.ethz.ch
Summary
Researchers engineered fibrin hydrogels to covalently incorporate vascular endothelial growth factor (VEGF) for enhanced angiogenesis. This biomaterial supports endothelial cell growth and holds potential for tissue regeneration in ischemic conditions.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Molecular Biology
Background:
- Vascular endothelial growth factor (VEGF) is crucial for blood vessel formation and tissue regeneration.
- Fibrin, a natural substrate for endothelial cells, is used clinically as fibrin glue.
- Stimulating angiogenesis is a therapeutic goal for tissue repair.
Purpose of the Study:
- To covalently incorporate VEGF into fibrin-based hydrogels to enhance angiogenic properties.
- To create a biomaterial that promotes endothelial cell growth and tissue regeneration.
Main Methods:
- Engineered a mutant VEGF(121) variant with an added factor XIIIa substrate sequence.
- Expressed and purified the modified VEGF(121) in E. coli.
- Covalently incorporated the modified VEGF(121) into fibrin hydrogels using factor XIIIa.
Main Results:
- The immobilized VEGF(121) retained its mitogenic activity for endothelial cells.
- VEGF-modified fibrin surfaces demonstrated dose-dependent enhancement of endothelial cell growth.
- Injectable VEGF-modified fibrin gels can be formed in vivo under physiological conditions.
Conclusions:
- Covalently linking VEGF to fibrin creates an effective angiogenic biomaterial.
- These VEGF-modified fibrin matrices show promise for stimulating tissue regeneration in ischemic areas.
- The engineered hydrogels offer a potential therapeutic strategy for angiogenesis-dependent conditions.